Story perspectives

Review Finds GLP-1s May Improve Obstructive Sleep Apnea Severity

9/9/2026

Summary

Story summary

University of Pittsburgh researchers reviewed evidence that GLP-1 receptor agonists may help obstructive sleep apnea.
Obstructive sleep apnea affects nearly 1 billion people worldwide and links to cardiovascular disease.
Obesity (BMI >= 30) appears in 60-70 % of sleep apnea patients.
Review appeared in JAMA Otolaryngology—Head and Neck Surgery on September 3, 2026, finding GLP-1s could improve severity.
Lead author Dr. Alex Harris said GLP-1s are not CPAP replacements and require long-term use.

1 of 1

Story summary

University of Pittsburgh researchers reviewed evidence that GLP-1 receptor agonists may help obstructive sleep apnea.
Obstructive sleep apnea affects nearly 1 billion people worldwide and links to cardiovascular disease.
Obesity (BMI >= 30) appears in 60-70 % of sleep apnea patients.
Review appeared in JAMA Otolaryngology—Head and Neck Surgery on September 3, 2026, finding GLP-1s could improve severity.
Lead author Dr. Alex Harris said GLP-1s are not CPAP replacements and require long-term use.